8-K
1
v010531_8k.txt
================================================================================
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
-----------------
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
-----------------
Date of Report (Date of earliest event reported): December 29, 2004
-----------------
NOVINT TECHNOLOGIES, INC.
(Exact name of registrant as specified in Charter)
DELAWARE 000-00000 85-0461778
(State or other jurisdiction of (Commission File No.) (IRS Employee
incorporation or organization) Identification No.)
4109 Bryan Ave NW
Albuquerque, New Mexico 87114
(Address of Principal Executive Offices)
866-298-4420
(Issuer Telephone Number)
================================================================================
Item 9.01 Financial Statements and Exhibits
The Registrant hereby presents its unaudited but reviewed financial statements
for the quarter ended September 30, 2004.
Novint Technologies, Inc.
BALANCE SHEETS
September 30, 2004 December 31, 2003
------------------ -----------------
ASSETS (Unaudited) (Audited)
CURRENT ASSETS:
Cash and cash equivalents $ 1,536,843 $ 32,119
Restricted cash (Note 3) -- 291,254
Marketable equity securities, available for sale (Note 4) 497 497
Prepaid interest expense -- 24,750
Prepaid private placement issuance costs -- 293,753
Prepaid consortium dues 11,250 --
Accounts receivable 132,690 81,865
Inventory -- --
Costs and estimated earnings in excess of billings on contracts (Note 5) 51,909 37,060
----------- -----------
Total current assets 1,733,189 761,298
----------- -----------
SOFTWARE DEVELOPMENT COSTS, NET (Note 6) 4,002 16,012
----------- -----------
PROPERTY AND EQUIPMENT:
Office equipment 46,632 45,586
Software 7,246 7,246
Computer equipment 187,359 155,067
----------- -----------
241,237 207,899
Less: Accumulated depreciation 157,145 124,146
----------- -----------
Total property and equipment 84,092 83,753
----------- -----------
INTANGIBLE ASSETS, NET (Note 7) 43,234 111,313
----------- -----------
Total assets $ 1,864,517 $ 972,376
=========== ===========
The accompanying notes are an integral part of these financial statements.
4
Novint Technologies, Inc.
BALANCE SHEETS
September 30, 2004 December 31, 2003
------------------ -----------------
(Unaudited) (Audited)
LIABILITIES AND STOCKHOLDERS' EQUITY
CURRENT LIABILITIES:
Accounts payable $ 65,638 $ 13,891
Accrued payroll related liabilities 11,209 175,846
Accrued consulting fees -- 86,380
Other accrued liabilities 70,855 46,687
Billings in excess of costs and estimated earnings 51,510 --
Notes payable, investor (Note 8) -- 100,000
Notes payable, net of discount (Note 8) -- 378,017
----------- -----------
Total current liabilities 199,212 800,821
----------- -----------
COMMITMENTS AND CONTINGENCIES (Note 9)
MANDATORILY REDEEMABLE, CONVERTIBLE
PREFERRED STOCK
Series A: aggregate liquidation preference, $100,000, $0.01 par
value; authorized 400,000 shares, issued and outstanding 239,827 145,388
----------- -----------
STOCKHOLDERS' EQUITY (Note 10):
Common stock, authorized 50,000,000 shares, $0.01 par value;
13,735,814 and 10,028,026 issued as of June 30, 2004 and
December 31, 2003, respectively; 13,535,814 and 10,028,026
outstanding as of June 30, 2004 and December 31, 2003,
respectively 135,858 100,280
Additional paid-in capital 5,643,260 2,147,028
Accumulated deficit (3,582,535) (2,211,586)
Accumulated other comprehensive loss (Note 4) (4,605) (4,605)
Unearned compensation (766,500) (4,950)
----------- -----------
Total stockholders' equity 1,425,478 26,167
----------- -----------
Total liabilities and stockholders' equity $ 1,864,517 $ 972,376
=========== ===========
The accompanying notes are an integral part of these financial statements.
5
Novint Technologies, Inc.
STATEMENTS OF OPERATIONS (Unaudited)
Three Months Ended Nine Months Ended
---------------------------- ----------------------------
9/30/2004 9/30/2003 9/30/2004 9/30/2003
------------ ------------ ------------ ------------
Revenue
Project $ 86,928 $ 94,131 $ 133,089 $ 234,454
Products 47,177 -- 91,172 143,678
------------ ------------ ------------ ------------
Total revenue 134,105 94,131 224,261 378,132
Cost of goods sold 72,526 87,601 155,824 255,327
------------ ------------ ------------ ------------
Gross margin 61,579 6,530 68,437 122,805
------------ ------------ ------------ ------------
Costs and expenses
Research and development 57,109 2,713 137,657 9,338
General and administrative 346,864 156,589 813,036 296,049
Depreciation and amortization 17,954 67,508 135,133 202,562
Sales and marketing 31,712 3,688 68,466 6,888
------------ ------------ ------------ ------------
Total costs and expenses 453,639 230,498 1,154,292 514,837
------------ ------------ ------------ ------------
Loss from operations (392,060) (223,968) (1,085,855) (392,032)
------------ ------------ ------------ ------------
Other expense
Realized loss on disposition of securities -- -- -- 239,040
Interest expense 1,599 1,875 190,655 3,750
------------ ------------ ------------ ------------
Total other expenses 1,599 1,875 190,655 242,790
------------ ------------ ------------ ------------
Loss before income taxes (393,659) (225,843) (1,276,510) (634,822)
Income tax expense -- -- -- --
------------ ------------ ------------ ------------
Net loss (393,659) (225,843) (1,276,510) (634,822)
Other comprehensive loss, net of tax
Change in unrealized loss on securities -- -- -- (10,416)
------------ ------------ ------------ ------------
Comprehensive loss (393,659) (225,843) (1,276,510) (645,238)
Preferred stock accretion (6,699) (3,948) (94,439) (11,516)
------------ ------------ ------------ ------------
Net loss available to common stockholders $ (400,358) $ (229,791) $ (1,370,949) $ (656,754)
============ ============ ============ ============
Loss per share, basic and diluted:
Net loss $ (0.03) $ (0.02) $ (0.10) $ (0.07)
============ ============ ============ ============
Net loss available to common stockholders $ (0.03) $ (0.02) $ (0.11) $ (0.07)
============ ============ ============ ============
Weighted-average common shares outstanding,
basic and diluted 13,216,147 9,274,020 12,747,270 9,295,140
============ ============ ============ ============
The accompanying notes are an integral part of these financial statements.
6
Novint Technologies, Inc.
STATEMENTS OF STOCKHOLDERS' EQUITY
Year Ended December 31, 2003 and Nine Months Ended September 30, 2004
Mandatorily Redeemable,
Convertible Preferred Stock Common Stock Additional
------------------------- ------------------------- Paid-in
Shares Amount Shares Amount Capital
----------- ----------- ----------- ----------- -----------
Balances, as restated, December 31, 2002 4,000 $ 129,811 9,244,834 $ 92,448 $ 1,380,703
Common stock issued to consultants for services -- -- 209,092 2,091 135,909
Common stock issued for Board of Directors services -- -- 30,304 303 19,697
Common stock issued for cash -- -- 378,788 3,788 246,212
Common stock issued for interest -- -- 50,000 500 32,500
Common stock issued upon exercise of options for cash -- -- 115,008 1,150 --
Options issued to consultants for services -- -- -- -- 55,776
Warrants issued in private placement transaction -- -- -- -- 85,007
Warrants issued in connection with notes payable -- -- -- -- 182,974
Executive compensation paid by shareholder -- -- -- -- 8,250
Amortization of unearned compensation -- -- -- -- --
Change in unrealized holding loss on investments -- -- -- -- --
Reclassification of realized loss on investments -- -- -- -- --
Preferred stock accretion -- 15,577 -- -- --
Net loss -- -- -- -- --
----------- ----------- ----------- ----------- -----------
Balances, December 31, 2003 4,000 $ 145,388 10,028,026 $ 100,280 $ 2,147,028
=========== =========== =========== =========== ===========
Common stock issued to consultants for services -- -- 110,000 1,100 108,900
Common stock issued for cash -- -- 378,788 3,788 246,212
Common stock and warrants issued in private
placement transaction, net of issuance costs -- -- 3,049,000 30,490 2,059,173
Options issued to employees for future services -- -- -- -- 806,500
Options issued to consultants for future services -- -- -- -- 26,735
Options issued to consultants for services -- -- -- -- 23,225
Cancelled options for employees -- -- -- -- (40,000)
Common stock issued upon exercise of options for services -- -- 20,000 200 --
Amortization of unearned compensation -- -- -- -- --
Modification of warrants issued in private placement transaction -- -- -- -- 265,488
Preferred stock accretion -- 94,439 -- -- --
Net loss -- -- -- -- --
----------- ----------- ----------- ----------- -----------
Balances, September 30, 2004 4,000 $ 239,827 13,585,814 $ 135,858 $ 5,643,260
=========== =========== =========== =========== ===========
Accumulated
Retained Other
Earnings Comprehensive Unearned
(Deficit) Loss Compensation Total
----------- ----------- ----------- -----------
Balances, as restated, December 31, 2002 $(1,205,459) $ (233,229) $ (10,300) $ 24,163
Common stock issued to consultants for services -- -- -- 138,000
Common stock issued for Board of Directors services -- -- -- 20,000
Common stock issued for cash -- -- -- 250,000
Common stock issued for interest -- -- -- 33,000
Common stock issued upon exercise of options for cash -- -- -- 1,150
Options issued to consultants for services -- -- -- 55,776
Warrants issued in private placement transaction -- -- -- 85,007
Warrants issued in connection with notes payable -- -- -- 182,974
Executive compensation paid by shareholder -- -- -- 8,250
Amortization of unearned compensation -- -- 5,350 5,350
Change in unrealized holding loss on investments -- (10,416) -- (10,416)
Reclassification of realized loss on investments -- 239,040 -- 239,040
Preferred stock accretion (15,577) -- -- (15,577)
Net loss (990,550) -- -- (990,550)
----------- ----------- ----------- -----------
Balances, December 31, 2003 $(2,211,586) $ (4,605) $ (4,950) $ 26,167
=========== =========== =========== ===========
Common stock issued to consultants for services -- -- -- 110,000
Common stock issued for cash -- -- -- 250,000
Common stock and warrants issued in private
placement transaction, net of issuance costs -- -- -- 2,089,663
Options issued to employees for future services -- -- (806,500) --
Options issued to consultants for future services -- -- -- 26,735
Options issued to consultants for services -- -- -- 23,225
Cancelled options for employees -- -- 40,000 --
Common stock issued upon exercise of options for services -- -- -- 200
Amortization of unearned compensation -- -- 4,950 4,950
Modification of warrants issued in private placement transaction -- -- -- 265,488
Preferred stock accretion (94,439) -- -- (94,439)
Net loss (1,276,510) -- -- (1,276,510)
----------- ----------- ----------- -----------
Balances, September 30, 2004 $(3,582,535) $ (4,605) $ (766,500) $ 1,425,478
=========== =========== =========== ===========
The accompanying notes are an integral part of these financial statements.
7
Novint Technologies, Inc.
STATEMENT OF CASH FLOWS (Unaudited)
Nine Months Ended
--------------------------
9/30/2004 9/30/2003
----------- -----------
Cash flows from operating activities:
Net loss $(1,276,510) $ (634,822)
Adjustments to reconcile net loss to net cash used in
operating activities
Depreciation and amortization 135,133 202,562
Common stock issued for services 110,000 44,500
Options issued to employees for services -- 49,581
Options issued to consultants for services 49,960 85,007
Options exercised for services performed 200 --
Discount on notes payable charged to interest expense 121,983 5,350
Reserve for conract loss -- 18,413
Amortization of unearned compensation 4,950 --
Services paid with investments -- 16,600
Realized loss on disposition of securities -- 239,040
Changes in operating assets and liabilities: --
Accounts receivable (50,825) (74,817)
Prepaid expenses 307,253 (79,382)
Accounts payable 51,747 (6,506)
Accrued liabilities (226,850) 73,953
Inventory -- --
Costs and estimated earnings in excess of billings
on contracts, net (14,849) 38,729
Billings in excess of costs and estimated earnings
on contracts, net 51,510 4,672
----------- -----------
Net cash used by operating activities (736,298) (17,120)
----------- -----------
Cash flows from investing activities:
Capital expenditures (55,383)
Lapse of restrictions on cash 291,254 (1,795)
----------- -----------
Net cash provided (used) by investing activities 235,871 (1,795)
----------- -----------
Cash flows from financing activities:
Proceeds from issuance of common stock 2,605,151 51,150
Repayment of notes payable, investor (100,000) --
Repayment of notes payable (500,000) --
----------- -----------
Net cash provided by financing activities 2,005,151 51,150
----------- -----------
Net decrease in cash and cash equivalents 1,504,724 32,235
Cash and cash equivalents at beginning of period 32,119 4,820
----------- -----------
Cash and cash equivalents at end of period $ 1,536,843 $ 37,055
=========== ===========
Supplemental information:
Interest paid $ 61,600 $ --
=========== ===========
Services paid with investments $ -- $ 16,600
=========== ===========
Fair value accretion on manditorily redeemable, convertible preferred stock $ 94,439 $ 7,568
=========== ===========
Modification of warrants issued in private placement transaction $ 265,488 $ --
=========== ===========
The accompanying notes are an integral part of these financial statements.
8
Novint Technologies, Inc.
NOTES TO FINANCIAL STATEMENTS (continued)
September 30, 2004
(unaudited)
NOTE 1 - PRESENTATION OF UNAUDITED FINANCIAL STATEMENTS
The accompanying interim financial data is unaudited, however in the opinion of
management, the interim data includes all adjustments, consisting of normal
recurring adjustments, necessary for a fair statement of the results for the
interim period. The financial statements included herein have been prepared by
Novint in accordance with the rules and regulations of the Securities and
Exchange Commission. Certain information and footnote disclosures normally
included in financial statements prepared in accordance with accounting
principles generally accepted in the United States of America have been
condensed or omitted pursuant to such rules and regulations, although Novint
believes that the disclosures included herein are adequate to make the
information presented not misleading.
The organization and business of Novint, accounting policies followed by Novint
and other information are contained in the notes to Novint's financial
statements filed as part of the Company's audited financial statements for the
year ended December 31, 2003 included in this registration statement. These
unaudited quarterly statements should be read in conjunction with the financial
statements as of and for the years ended December 31, 2003 and 2002 included in
this Registration Statement. In the opinion of management, the accompanying
interim financial statements reflect all adjustments necessary for the fair
presentation of the financial position, results of operations, and cash flows
for the interim periods presented. Adjustments, if any, are reflected in the
current quarter balances. The results of operations for interim periods are not
necessarily indicative of results which may be expected for any other interim
period or for the year ending December 31, 2004.
NOTE 2 - CAPITAL RESOURCES
Since inception, Novint has incurred net operating losses and other equity
charges which have resulted in an accumulated deficit of $3,582,535 at September
30, 2004 and operations using net cash of $736,298 during the first nine months
of 2004. Management has raised equity totaling approximately $5.7 million
through various private equity transactions. Management believes the proceeds
from these private placements, along with revenues from project and product
sales, will allow Novint to satisfy its short and long-term obligations and
provide enough cash flow for Novint to continue operations through September 30,
2005. The accompanying financial statements have been prepared in conformity
with accounting principles generally accepted in the United States of America,
which contemplate continuation of Novint as a going concern. Should Novint be
unable to raise additional capital or ramp up product sales, additional
adjustments may be required.
In May 2004, Novint completed a private placement raising gross proceeds of
$909,000 in exchange for 909,000 shares of common stock at an exercise price of
$1.00 per share and warrants to purchase 454,500 shares of common stock with an
exercise price of $2.00 per share. After cash fees incurred in connection with
this placement, net cash proceeds to Novint were $850,270.
In February 2004, Novint completed a private placement raising gross proceeds of
$2,140,000 in exchange for 2,140,000 shares of common stock at an exercise price
of $1.00 per share and warrants to purchase 1,070,000 shares of common stock
with an exercise price of $2.00 per share. After cash fees incurred in
connection with this placement, net cash proceeds to Novint were $1,505,393.
On January 31, 2004, Novint entered into a stock purchase agreement with a
private investor. In connection with this agreement, Novint issued 378,788
shares of its common stock for $0.66 per share and received gross proceeds of
$250,000.
Novint issued 300,000 warrants to their attorney for services rendered in
connection with the private placement. Such costs, totaling approximately
$266,000 for the nine months ended September 30, 2004, have been netted against
the proceeds from the private placement in the accompanying statement of
stockholders' equity. See Note 11.
9
Novint Technologies, Inc.
NOTES TO UNAUDITED FINANCIAL STATEMENTS
September 30, 2004
NOTE 3 - SUMMARY OF CHANGES IN SIGNIFICANT ACCOUNTING POLICIES
Restricted Cash
In connection with Novint's private placement, a loan of $500,000 was provided
in November 2003 for use solely with private placement expenses and a hardware
licensing agreement with a third party. As of December 31, 2003, Novint had
approximately $291,000 in cash on hand restricted for use to close the private
placement and payment of milestones pursuant to the licensing agreement. As of
September 30, 2004, the $500,000 loan was repaid and the restriction on the cash
was lifted.
Accounts Receivable/Concentration of Credit Risk
Novint utilizes the allowance method for accounts receivable valuation,
providing for allowances for estimated uncollectible accounts receivable. At
September 30, 2004 and December 31, 2003, management believes all receivables
are collectible; therefore, no allowances have been provided. Novint's financial
instruments that are exposed to concentration of credit risk consist primarily
of uninsured cash, cash equivalents and available-for- sale securities held at
commercial banks and institutions primarily in the United States and trade
receivables from Novint's customers. For the nine months ended September 30,
2004, Novint had sales to four customers that accounted for approximately 36%,
22%, 21%, and 13% of its sales. For the nine months ended September 30, 2003,
Novint had sales to three customers that accounted for approximately 39%, 35%
and 10% of its sales. Novint routinely assesses the financial strength of its
customers as part of its consideration of accounts receivable collectibility by
performing credit evaluations of customers. Trade receivables are not
collateralized. Novint generally grants credit terms to most customers ranging
from 30 to 90 days. For the nine months ended September 30, 2004 and 2003,
Novint's revenues were substantially earned from a government agency
headquartered in New Mexico and several government contractors located in the
United States. As of September 30, 2004 and 2003, Novint's trade receivables
were substantially due from several prominent government contractors located in
the United States.
Inventory
Novint values its material inventory at the lower of cost or market. Cost is
determined on the first-in, first-out ("FIFO") method. Novint evaluates the need
to record adjustments for impairment of inventory on a periodic basis and any
required adjustment is made to record inventory at its estimated net realizable
value. Novint had no inventory at September 30, 2004 or December 31, 2003.
Intangible Assets
Intangible assets, which consist of licensing agreements and a patent, are
carried at cost less accumulated amortization. Amortization is computed using
the straight-line method over the economic life of the asset, or useful life of
the license agreements, which are 3 and 12 years. For the 9 months ended
September 30, 2004 and the year ended December 31, 2003, Novint recognized
amortization expense of approximately $90,000 and $221,000, respectively,
related to the intangible assets.
10
Novint Technologies, Inc.
NOTES TO UNAUDITED FINANCIAL STATEMENTS
September 30, 2004
Impairment of Long-Lived Assets and Long-Lived Assets to be Disposed Of
Novint reviews its long-lived assets for impairment whenever events or changes
in circumstances indicate that the carrying amount of an asset may not be
recoverable. Recoverability of assets to be held and used is measured by a
comparison of the carrying amount of an asset to future net cash flows expected
to be generated by the asset. If such assets are considered to be impaired, the
impairment to be recognized is measured by the amount by which the carrying
amount of the assets exceeds the fair value of the assets. Assets to be disposed
of are reported at the lower of the carrying amount or fair value less costs to
sell. No impairment loss was recorded in 2004 or 2003.
Loss per Common Share
The Financial Accounting Standards Board (FASB) issued SFAS 128, Earnings Per
Share, which is effective for periods ending after December 15, 1997. SFAS 128
provides for the calculation of "Basic" and "Diluted" earnings per share. Basic
earnings per share includes no dilution and is computed by dividing loss to
common shareholders by the weighted average number of common shares outstanding
for the period.
All potentially dilutive securities have been excluded from the computations
since they would be antidilutive. However, these dilutive securities could
potentially dilute earnings per share in the future. As of September 30, 2004
and 2003, Novint had a total of 9,201,338 and 5,515,565 potentially dilutive
securities, respectively.
Stock Option Plans
Novint applies the intrinsic value-based method of accounting prescribed by
Accounting Principles Board (APB) Opinion No. 25, Accounting for Stock Issued to
Employees, and related interpretations, in accounting for the recognition and
measurement of its fixed plan stock options. As such, unearned compensation is
recorded on the date of grant if the current market price of the underlying
stock exceeds the exercise price, and is amortized over the service period. As
of September 30, 2004 and December 31, 2003, amortization of unearned
compensation approximates $5,000 and $5,000, respectively.
SFAS 123, Accounting for Stock-Based Compensation, established accounting and
disclosure requirements using a fair value-based method of accounting for
stock-based employee compensation plans. As permitted by SFAS 123, Novint has
elected to continue to apply the intrinsic value-based method of accounting
described above, and has adopted the disclosure-only requirements of SFAS l23.
The following table illustrates the effect on net loss to common stockholders if
Novint had applied the fair value recognition provisions of SFAS 123 to all
stock-based employee compensation for the nine month period ended September 30.
EPS has been calculated after the accretion of the preferred stock:
11
Novint Technologies, Inc.
NOTES TO UNAUDITED FINANCIAL STATEMENTS
September 30, 2004
September 30, September 30,
2004 2003
(unaudited) (unaudited)
----------- -----------
Net loss, as reported $(1,276,510) $ (634,822)
Add: Stock-based employee compensation
expense included in reported net income 4,950 5,350
Deduct: Total stock based employee
compensation expense determined under fair
value based method for all awards (18,018) (154,602)
----------- -----------
Pro forma net loss $(1,289,578) $ (784,074)
=========== ===========
Loss per share, basic and diluted:
As reported $ (0.10) $ (0.07)
Pro forma $ (0.10) $ (0.08)
In calculating the fair value of options for the above pro forma disclosure, the
following assumptions were used for the quarter ended September 30, 2004: a risk
free rate of 3.27%, volatility of Novint's stock of 100%, estimated lives of the
options of 3 years, an exercise price of $0.66 per share, and a fair market
value of $1.00 per share.
Reclassifications
Certain reclassifications have been made to prior year or quarter balances in
order to conform to the current year or quarter presentation.
NOTE 4 - MARKETABLE EQUITY SECURITIES
In September 2000, Novint entered into a Research and Development contract to
provide to Manhattan Scientifics, Inc. (Manhattan), a publicly-traded company
located in New York, a license and rights to sublicense haptics technology.
Coincident with the contract agreement, Novint and Manhattan entered into an
exchange transaction that was finalized in May 2001, whose terms provided that
Manhattan would receive 4,067,200 shares of Novint's stock, and Novint would
receive 1,000,000 shares of Manhattan stock. In addition, Novint obtained from
Manhattan exclusive ownership of the worldwide IP rights and associated
obligations of Teneo, a privately owned company previously acquired by
Manhattan. The rights in Teneo are recorded on the accompanying September 30,
2004 and December 31, 2003 balance sheets as licensing agreements (see Note 7).
At September 30, 2004 and December 31, 2003, Novint held 8,284 shares of the
original 1,000,000 shares of Manhattan common stock acquired in the exchange
transaction, with original cost basis of $5,102. At September 30, 2004 and
December 31, 2003, there were unrealized holding losses of $4,605 related to its
investment in marketable equity securities, which have been presented as
accumulated other comprehensive losses in the statement of stockholders' equity.
NOTE 5 - COSTS AND ESTIMATED EARNINGS IN EXCESS OF BILLINGS ON CONTRACTS
Costs and estimated earnings in excess of billings on contracts consist of the
following at:
September 30, December 31,
2004 2003
(Unaudited) (Audited)
------------ ------------
Costs and estimated earnings on uncompleted contracts $ 51,909 $ 67,000
Billings on uncompleted contracts -- (29,940)
------------ ------------
Costs and estimated earnings in excess of billings on
uncompleted contracts $ 51,909 $ 37,060
============ ============
Billings in excess of costs and estimated earnings on contracts consist of the
following at December 31:
September 30, December 31,
2004 2003
(Unaudited) (Audited)
------------ ------------
Billings on uncompleted contracts $ 132,690 $ --
Costs and estimated earnings on uncompleted contracts 81,180 --
------------ ------------
Billings in excess of costs and estimated earnings on
uncompleted contracts $ 51,510 $ --
============ ============
12
Novint Technologies, Inc.
NOTES TO UNAUDITED FINANCIAL STATEMENTS
September 30, 2004
NOTE 6 - SOFTWARE DEVELOPMENT COSTS
Capitalized software development costs consisted of the following at:
September 30, December 31,
2004 2003
(Unaudited) (Audited)
------------ ------------
Software development costs $ 80,058 $ 80,058
Less accumulated amortization 76,056 64,046
------------ ------------
$ 4,002 $ 16,012
============ ============
NOTE 7 - INTANGIBLE ASSETS
Intangible assets consisted of the following at:
September 30, December 31,
2004 2003
(Unaudited) (Audited)
------------ ------------
Licensing agreement $ 680,000 $ 665,000
Patent 10,734 3,688
Less accumulated amortization (647,500) (557,375)
------------ ------------
$ 43,234 $ 111,313
============ ============
NOTE 8 - NOTES PAYABLE
In October 2002, Novint issued a promissory note of $100,000 with a maturity
date of October 2003. During 2003, the maturity date was extended to October
2004. Novint repaid the $100,000 note in full in March 2004. In conjunction with
the issuance of the $100,000 promissory note in October 2002, Novint issued
150,000 shares of common stock at a fair value of $0.05 per share in lieu of
interest. Novint determined the fair value of their common stock to be $0.05 per
share as determined by its Board of Directors based on the value of other
instruments issued, such as preferred stock, during the prior year. In October
2003, as a result of the repayment extension and in accordance with the original
terms of the promissory note, Novint issued an additional 50,000 shares of
common stock at a fair value of $0.66 per share. Novint determined the fair
value of their common stock to be $0.66 per share as a result of a third party
common stock sale. The fair market value of the shares issued in lieu of
interest has been recorded as interest expense over the term of the note. The
fair value of the shares issued in 2003 total $33,000. During the year ended
December 31, 2003, Novint recorded $8,250 on shares issued in 2003 as interest
expense, and $24,750 was prepaid interest expense. The remaining fair value of
$24,750 was properly recognized as interest expense during the 9 months ended
September 30, 2004 upon repayment of the note.
In November 2003, Novint issued a promissory note, which is secured by all of
Novint's assets, of $500,000 with an interest rate of 12% per annum, maturity
date of May 2004. During the 9 months ended September 30, 2004, Novint fully
repaid this note, along with $60,000 of interest. In conjunction with the
issuance of the $500,000 promissory note, Novint issued a warrant for the
purchase of 500,000 shares of Novint's common stock at an exercise price of
$0.50 per share. The warrant expires in November 2013. Novint calculated the
relative fair value of the warrant to be approximately $183,000 using the
Black-Scholes model based on the following assumptions: a risk-free rate of
4.31%, volatility of 86%, contractual life of 10 years, and a common stock fair
market value of $0.66 per share. As these warrants were issued in connection
with a note, the value of the warrant was recorded as a debt discount. At
December 31, 2003, the unamortized discount totaled $122,000. This amount was
charged to interest expense during the nine months ended September 30, 2004.
13
Novint Technologies, Inc.
NOTES TO UNAUDITED FINANCIAL STATEMENTS
September 30, 2004
NOTE 9 - INCOME TAXES
Deferred income taxes reflect the tax consequences on future years for
differences between the tax basis of assets and liabilities and their basis for
financial reporting purposes. Temporary differences giving rise to the current
deferred tax asset are the accrual for billings in excess of costs and estimated
earnings and accounts payable, which are recorded for financial reporting
purposes but not currently deductible for tax reporting. Temporary differences
giving rise to the non-current deferred tax asset include accrued payroll not
paid and contribution carryover, which are deductible for financial reporting
purposes but not currently deductible for tax reporting. The other major
temporary timing differences giving rise to the non-current deferred tax asset
is the net operating loss carryforward. The temporary differences giving rise to
the current deferred tax liability consist of accounts receivable, prepaid
expenses and costs and estimated earnings in excess of billings that are accrued
for financial reporting purposes but are not currently includible for tax
reporting purposes. The temporary differences giving rise to the non-current
deferred tax liability consist of the software costs that have been capitalized
for financial reporting purposes but are deductible for tax reporting purposes.
As a result of the significant net losses incurred during 2004 and in prior
years and potential statutory limitations on the ability to recognize these
losses, Novint recorded a valuation allowance to fully reserve its net deferred
tax asset.
NOTE 10 - COMMITMENTS AND CONTINGENCIES
Novint has a month-to-month operating lease of $800 per month for office space.
The monthly rent shall be paid in either cash or Manhattan Scientifics
("Manhattan") common stock in an amount of shares calculated based on the
closing price of Manhattan stock on the previous trading day. Novint has no
further relationship with the lessor beyond the lease agreement.
Novint has a licensing agreement with Sandia National Laboratories (Sandia),
which initially developed Flight, the precursor to e-TouchTM (the technology),
and employed Novint's founder. The licensing agreement provides Novint the right
to utilize the technology exclusively for a period of 12 years and
non-exclusively in perpetuity and places certain restrictions on its use as well
as requires Novint to pay 1.5 percent royalty fees to Sandia in connection with
any income earned based upon the technology. Additionally, Novint is obligated
to pay to Sandia on a semi-annual basis annual minimum earned royalties of
$6,000 in 2001, $14,000 in 2002, $24,000 in 2003, and $30,000 from 2004 through
2011. The agreement also allows for sub-licensure of the technology to others,
which was provided to Manhattan under an agreement dated September 24, 2000. As
of September 30, 2004 and December 31, 2003, Novint had accrued approximately
$22,500 and $24,000, respectively, in royalty fees owed to Sandia under the
royalty agreement. Amounts owed to Sandia as of December 31, 2003 were paid in
full during 2004.
From time to time, in the normal course of business, Novint is subject to
routine litigation incidental to their business. Although there can be no
assurances as to the ultimate disposition of any such matters, it is the opinion
of management, based upon the information available at this time, that there are
no matters, individually or in the aggregate, that will have a material adverse
effect on the results of operations and financial condition of Novint.
In September 2004, Novint signed an agreement with Lunar Design, a product
design firm, to design and develop their Haptics game controller. The work is
estimated to take up to 9 months. Estimated costs will range between
approximately $542,000 and $634,000, which will be billed on a time and
materials basis. Lunar Design has agreed to accept payment in the form of cash,
promissory note, or Novint common stock. As of September 30, 2004, no amounts
have been paid to Lunar Design.
14
Novint Technologies, Inc.
NOTES TO UNAUDITED FINANCIAL STATEMENTS
September 30, 2004
NOTE 11 - STOCKHOLDERS' EQUITY
Mandatorily Redeemable, Convertible Preferred Stock
Novint is authorized to issue a maximum of 4,000 shares of preferred stock with
$0.01 par value. On April 20, 2000, in connection with the license agreement
with Sandia, Novint issued 4,000 shares of Series A mandatorily redeemable,
convertible preferred stock at $0.25 per share. The preferred stock is
convertible into fully paid and nonassessable common stock as follows: at the
holder's option based on the conversion price in effect on the conversion date,
or automatically upon the closing of an initial public offering which would
result in 447,300 shares of common stock. The conversion price is to be (i) the
subscription price ($100,000 when expressed as an aggregate amount, or $0.25 per
share when expressed on a per share basis) divided by (ii) the conversion price
in effect on the conversion date. Additionally, Novint is obligated to redeem
the preferred shares, if there is no public offering (initial public offering or
"IPO") or initial sale within 10 years from the issue date. If there is no IPO,
Novint shall repurchase the number of shares of preferred stock as the holders
thereof may from time to time request, but in any 12 month period, not more than
10% of the largest number of shares of preferred stock that have ever been
outstanding, at an amount per share equal to the redemption price. The
redemption price is the greater of (a) the subscription price, and (b) that
portion of the fair market value of Novint, as determined in good faith by the
Board of Directors, corresponding to the number of shares of common stock to
which the shares of preferred stock to be redeemed would convert according to
the conversion provisions.
Accordingly, Novint has accreted the fair value of the common stock conversion
to retained earnings over the 10 year life of the preferred stock. If an IPO
occurs, Novint will recognize an additional charge to retained earnings of the
converted shares at the fair value as compared to the IPO price. At September
30, 2004, the unaccreted fair value of the preferred stock totaled $239,827
based on the fair value of the stock at September 30, 2004 of $1.00 per share.
Upon conversion, the preferred stock will be reclassified to common stock
outstanding. The holders of the issued and outstanding shares of preferred stock
shall have no voting rights. In all respects regarding dividends or
distributions of any kind to holders of common stock, holders of preferred stock
shall have the rights, privileges, and share in all respects as if such holders
had converted the preferred stock to the number of shares of common stock
corresponding to their conversion provisions. In the event of any voluntary or
involuntary liquidation, dissolution or other winding up of Novint, the holders
of the preferred stock shall be entitled to be paid the subscription price of
all outstanding shares of preferred stock, in cash or in property taken at its
fair value as determined by the Board of Directors, or both, at the election of
the Board of Directors, prior to any distribution to the holders of common
stock.
Common Stock
Novint is authorized to issue a maximum of 50,000,000 shares of common stock
with a par value of $0.01 per share. For the period ended September 30, 2004 and
the year ended December 31, 2003, Novint had 13,735,814 and 10,028,026 shares
outstanding, respectively, and 13,535,814 and 10,028,025 shares issued,
respectively.
Private Placement
A private placement offering was completed in February 2004 for $2,140,000. In
connection with this offering, Novint issued 2,140,000 shares of common stock at
an exercise price of $1.00 per share and warrants to purchase 1,070,000 shares
of common stock at an exercise price of $2.00 per share. Novint received net
cash proceeds of $1,505,393 (after fees were paid to their placement agent and
lawyers).
A second closing of the private placement offering was completed in May 2004 for
$909,000. In connection with this offering, Novint issued 909,000 shares of
common stock at an exercise price of $1.00 per share and warrants to purchase
454,500 shares of common stock at an exercise price of $2.00 per share. Novint
received net cash proceeds of $850,440 (after fees were paid to their placement
agent and lawyers).
15
Novint Technologies, Inc.
NOTES TO UNAUDITED FINANCIAL STATEMENTS
September 30, 2004
Equity Transactions
On January 31, 2004, Novint entered into a stock purchase agreement with a
private investor. In connection with this agreement, Novint issued 378,788
shares of its common stock at $0.66 per share and received gross proceeds of
$250,000. The share price was based on a prior agreement with this investor.
On February 25, 2004, Novint issued 10,000 shares of common stock at $1.00 per
share to a consultant for services performed. Novint recognized $10,000 in
consulting expense related to this issuance.
On April 1, 2004, Novint committed to issue 250,000 shares of common stock at
$1.00 per share to a consultant for future services. Vesting terms are as
follows: 50,000 shares per quarter as long as the consultant is still providing
services to Novint, up to a total of 250,000 shares, beginning April 1, 2004,
Novint recognized $100,000 in consulting expense related to this issuance as of
September 30, 2004.
On April 8, 2004, Novint issued 20,000 shares of its common stock in connection
with option exercises at $0.01 per share.
On July 7, 2004, Novint committed to issue 10,000 shares of common stock at
$1.00 per share to an employee for future services. Stock vests on July 7, 2005,
and as such Novint had not recognized any expense related to this issuance as of
September 30, 2004.
Options and Warrants
On February 18, 2004, Novint granted 1,205,000 options at an exercise price of
$0.50 per share, with a 5-year annual vesting provision, to purchase common
stock to various employees. These options had intrinsic value because the
exercise price of $0.50 per share was less than the fair market value of $1.00
per share. Unearned compensation of $602,500 was recorded at the measurement
date and will be amortized over the vesting period.
On February 18, 2004, Novint granted to a consultant for future services 125,000
options to purchase common stock at an exercise price of $0.50 per share. The
options have a 5-year annual vesting provision. Novint calculated the value of
the options using the Black-Scholes model based on the following assumptions: a
risk-free rate of 4.05%, volatility of 91%, estimated life of 10 years, and a
fair market value of $1.00 per share. On June 10, 2004, Novint granted to
various consultants for future services 300,000 options to purchase common stock
at an exercise price of $0.66 per share. The options have a 5-year annual
vesting provision. Novint calculated the value of these options using the
Black-Scholes model based on the following assumptions: a risk-free rate of
4.81%, volatility of 100%, estimated life of 10 years, and a fair market value
of $1.00 per share. The vesting schedules are prorated over the reporting
period, and approximately $53,000 was recorded as consultant expense during the
9 months ended September 30, 2004.
On June 10, 2004, Novint granted 500,000 options at an exercise price of $0.66
per share, with a 5-year annual vesting provision, to purchase common stock to
an employee. These options had intrinsic value because the exercise price of
$0.66 per share was less than the fair market value of $1.00 per share. Unearned
compensation of $170,000 was recorded at the measurement date and will be
amortized over the vesting period.
On July 20, 2004, Novint granted 50,000 options at an exercise price of $0.66
per share, with a 5-year annual vesting provision, to purchase common stock to
an employee. These options had intrinsic value because the exercise price of
$0.66 per share was less than the fair market value of $1.00 per share. Unearned
compensation of $17,000 was recorded at the measurement date and will be
amortized over the vesting period.
On August 9, 2004, Novint granted 50,000 options at an exercise price of $0.66
per share, with a 5-year annual vesting provision, to purchase common stock to
an employee. These options had intrinsic value because the exercise price of
$0.66 per share was less than the fair market value of $1.00 per share. Unearned
compensation of $17,000 was recorded at the measurement date and will be
amortized over the vesting period.
On August 9, 2004, Novint cancelled 80,000 options previously granted at an
exercise price of $0.50 per share, with a 5-year annual vesting provision, to
purchase common stock to an employee. These options had intrinsic value because
the exercise price of $0.66 per share was less than the fair market value of
$1.00 per share. Unearned compensation of $40,000 had been recorded at the
measurement date and was reversed at September 30, 2004.
16
Novint Technologies, Inc.
NOTES TO UNAUDITED FINANCIAL STATEMENTS
September 30, 2004
On June 10, 2004, Novint granted to a former Board of Director providing
consulting services for services 25,000 options to purchase common stock at an
exercise price of $0.66 per share. These options immediately vest. Novint
calculated the value of these options using the Black-Scholes model based on the
following assumptions: a risk-free rate of 4.81%, volatility of 100%, estimated
life of 10 years, and a fair market value of $1.00 per share. Approximately
$23,000 was recorded as consultant expense during the 9 months ended September
30, 2004.
Warrants
In September 2003, Novint issued 300,000 warrants to an attorney for services
rendered in connection with a private placement at an exercise price of $0.66
per share. These warrants vested 50% upon issuance in September 2003, and 50%
on the 1st anniversary date (September 2004) of the execution date of this
warrant provided that the holder continued to represent the company as its legal
counsel on such vesting date. In March 2004, Novint amended the exercise price
from $0.66 per share to $0.50 per share to compensate them fairly for their
services. As the terms of the original Warrant agreement do not specifically
address how such modifications should be treated, Novint has recorded an
additional approximately $105,000, which represents the difference in the fair
value of this modification. The following assumptions were used for the quarter
ended March 31, 2004 in calculating the fair value difference of this warrant
modification under the Black-Scholes model: risk free rate of 3.75%, volatility
of 91%, contractual term of 10 years, exercise price of $0.50 per share, and
fair market value of $1.00 per share. Novint recognized the remaining 50%
value of the warrant during the quarter ended September 30, 2004. The following
assumptions were used for the quarter ended September 30, 2004 in calculating
the fair value of this warrant under the Black-Scholes model: risk free rate of
4.14%, volatility of 79%, contractual term of 10 years, exercise price of $0.50
per share, and fair market value of $1.00 per share. A total amount of
approximately $266,000 has been recorded to reflect the fair value of these
warrants, which have been recorded as a reduction of the offering proceeds in
the statement of stockholders' equity.
In March 2004, Novint issued 200,000 warrants to a consulting group for services
rendered in connection with a private placement at an exercise price of $1.00
per share. The warrants vested immediately, and have a life of 5 years. The fair
market value of the warrants totaled approximately $142,000. Novint calculated
the warrant expense using the Black-Scholes model based on the following
assumptions: a risk-free rate of 2.39%, volatility of 91%, estimated life of 5
years, and a fair market value of $1.00 per share. As of September 30, 2004,
Novint recognized this amount as a reduction of the offering proceeds.
In April 2004, Novint issued 263,500 warrants to a consulting group for services
rendered in connection with a private placement at an exercise price of $1.00
per share. The warrants vested immediately, and have a life of 5 years. The fair
market value of the warrants totaled approximately $200,000. Novint calculated
the warrant expense using the Black-Scholes model based on the following
assumptions: a risk-free rate of 3.49%, volatility of 100%, estimated life of 5
years, and a fair market value of $1.00 per share. As of September 30, 2004,
Novint recognized this amount as reduction of the offering proceeds.
In May 2004, Novint issued 250,000 warrants to a consultant for services to be
rendered in connection with its marketing strategy. The warrants will have an
exercise price of $1.00 per share and will vest at a rate of 10,000 shares for
each $1,000,000 in contract revenue associated with the consultant's efforts. As
no associated revenue had been recorded for the 9 months ended September 30,
2004, no impact is reflected on the accompanying financial statements.
During the 9 months ended September 30, 2004, Novint committed to issue 304,900
warrants in connection with an over allotment agreement with a consulting group
for private placement services. The warrants will have an exercise price of
$1.00 per share and will have a six-month term. The date of issue will be
coincident with the date of Novint's initial public offering. As Novint is
currently undergoing initial public offering procedures and does not know of
their initial public offering date, these warrants are not outstanding as of
September 30, 2004.
17
Novint Technologies, Inc.
NOTES TO UNAUDITED FINANCIAL STATEMENTS
September 30, 2004
NOTE 12 - RELATED PARTIES
In April 2000, Sandia licensed to Novint the right to utilize the Flight
technology, which is the precursor to e-TouchTM, exclusively for a period of 12
years and non-exclusively in perpetuity, as well as requiring Novint to pay 1.5
percent royalty fees to Sandia in connection with any income earned based upon
the technology. In connection with this licensing agreement, Novint issued 4,000
shares of Series A mandatorily redeemable, convertible preferred stock, which
can be converted into 447,300 shares of common stock. The preferred stock is
convertible into fully paid and nonassessable common stock as follows: at the
holder's option based on the conversion price in effect on the conversion date,
or automatically upon the closing of an initial public offering. The conversion
price is to be (i) the subscription price ($100,000 when expressed as an
aggregate amount, or $25 per share when expressed on a per share basis) divided
by (ii) the conversion price in effect on the conversion date. Additionally,
during November 2002, Novint issued to Sandia 40,000 shares of common stock as
repayment of their 2001 and 2002 royalty fees, which totaled $20,000, at $0.50
per share.
As of December 31, 2003, Novint had a loan outstanding for $100,000 from an
investor. This loan was repaid in March 2004.
Manhattan Scientifics ("Manhattan") is Novint's main investor with approximately
30% and 41% ownership in Novint as of September 30, 2004 and December 31, 2003,
respectively. During the nine months ended September 30, 2004, Manhattan
provided consulting services to Novint in relation to their long-term strategic
planning. As of September 30, 2004, Novint had paid $40,000 for these services.
On February 25, 2004, Novint issued 10,000 shares of common stock at $1.00 per
share to a former Board of Director for consulting services performed. Novint
recognized $10,000 in consulting expense based on the fair market value of the
shares, when these shares were issued.
In March 2004, Normandie New Mexico Corporation, which is owned by Manhattan's
Chief Executive Officer (CEO), who is also a member of Novint's Board of
Directors, entered into an agreement with Novint to provide consulting services
in relation to business development and marketing support. Fees per the
agreement are $6,250 per month. For the nine months ended September 30, 2004,
Novint had paid $43,750 for these services.
On April 1, 2004, Novint committed to issue 250,000 shares of common stock at
$1.00 per share to Manhattan's Chief Operating Officer (COO) for future
consulting services. Vesting terms are as follows: 50,000 shares per quarter as
long as the COO is still providing services to Novint, up to a total of 250,000
shares, beginning April 1, 2004. Novint recognized $100,000 in consulting
expense related to this issuance during the nine months ended September 30,
2004.
On June 10, 2004, Novint granted 250,000 options to purchase common stock to
Manhattan's CEO for future consulting services at an exercise price of $0.66 per
share. The options have a 5-year annual vesting provision. Novint calculated the
value of these options using the Black-Scholes model based on the following
assumptions: a risk-free rate of 4.81%, volatility of 100%, estimated life of 10
years, and a fair market value of $1.00 per share. The vesting schedule is
prorated over the reporting period, and approximately $13,000 was recorded as
consultant expense during the nine months ended September 30, 2004.
18
Novint Technologies, Inc.
NOTES TO UNAUDITED FINANCIAL STATEMENTS
September 30, 2004
On June 10, 2004, Novint granted 25,000 options to purchase common stock to a
former member of the Board of Directors for consulting services at an exercise
price of $0.66 per share. These options immediately vest. Novint calculated the
value of these options using the Black-Scholes model based on the following
assumptions: a risk-free rate of 4.81%, volatility of 100%, estimated life of 10
years, and a fair market value of $1.00 per share. Approximately $23,000 was
recorded as consultant expense during the 9 months ended September 30, 2004.
During the quarters ended September 30, 2004 and 2003, Novint developed
professional applications for Sandia. Novint recognized approximately $81,000
and $154,000 in revenues from Sandia during the nine months ended September 30,
2004 and 2003.
19
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
Dated: December 29, 2004 NOVINT TECHNOLOGIES, INC.
By: /s/ Tom Anderson
-----------------------------------
Tom Anderson
Its: Chief Executive Officer and
Acting Chief Financial Officer
20